Skip to main content
. 2012 Nov 1;13(13):1244–1254. doi: 10.4161/cbt.21460

graphic file with name cbt-13-1244-g1.jpg

Figure 1. Chemical structure of oridonin and cytotoxic effect of oridonin alone or in combination with imatinib on SUP-B15 cells. (A) chemical structure of oridonin.B, SUP-B15 cells were incubated with 0, 5, 7.5, 10, 12.5 μM oridonin for 1 d, 3 d and 5 d. At the end of incubation, MTT methods determined the cell survival rates. Cell viability is expressed as the percentage of cell survival compared with the control. (B) SUP-B15 cells were incubated with imatinib alone or in combination with 1 μM, 2 μM and 3 μM oridonin for 72 h. At the end of incubation, MTT methods were used to determine the cell survival rates and the IC50 of imatinib. (C) The cell viability treated with imatinib alone or in combination with indicated concentration of oridonin for 72 h. D,The IC50 of imatinib alone or in combination with indicated concentration of oridonin for 72 h. Data were from three independent experiments. *p < 0.05 was used to compare the effects of compounds.